Gyre Pharmaceuticals Co., Ltd. Honored with the “Outstanding Innovative Enterprise Award”
2024-12-17
Recently, the Beijing Enterprise Evaluation Association has announced the results of the 2...
Milestone in Phase III Clinical Trial of Hydronidone (F351) of Gyre Pharmaceuticals
2024-10-23
Gyre Pharmaceuticals (also known as Beijing Continent Pharmaceuticals) announced the succe...
GYRE Pharmaceuticals Co., Ltd. is Honored to be Included in the National “Little Giant” Enterprises that Use Specialized and Sophisticated Technologies to Produce Novel and Unique Products
2024-09-19
Recently, the Beijing Municipal Bureau of Economy and Information Technology officially an...